ADVISORY RESEARCH INC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$1,311,825
-10.6%
25,276
+3.3%
0.18%
-3.2%
Q2 2023$1,466,862
+45.5%
24,464
+20.0%
0.19%
+13.3%
Q1 2023$1,008,131
-17.5%
20,391
-4.7%
0.17%
+44.3%
Q4 2022$1,221,356
-4.2%
21,401
-21.2%
0.12%
-8.0%
Q3 2022$1,275,00027,1710.12%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$34,592,30327.53%
RTW INVESTMENTS, LP 6,029,633$361,536,7956.88%
Paradigm Biocapital Advisors LP 1,270,124$76,156,6355.88%
Rock Springs Capital Management LP 3,028,410$181,583,4644.32%
Logos Global Management LP 500,000$29,980,0004.08%
TANG CAPITAL MANAGEMENT LLC 405,600$24,319,7763.58%
GREAT POINT PARTNERS LLC 297,082$17,813,0373.49%
Eschler Asset Management LLP 34,000$2,038,6402.89%
COWEN AND COMPANY, LLC 460,036$27,583,7582.29%
HighVista Strategies LLC 44,094$2,643,8761.21%
View complete list of IMMUNOCORE HLDGS PLC shareholders